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Theiler’s murine encephalomyelitis viruses (TMEV) are divided into two groups: high-neurovirulence strains, such as GDVII,
cause fatal encephalitis, while low-neurovirulence strains, such as BeAn and DA, cause persistent infection and demyeli-
nation in mice. Cell surface sialic acid is bound by the low-neurovirulence DA and BeAn viruses, but not by the high-
neurovirulence GDVII virus. We have identified a clone from a BHK-21 cell cDNA library that mediates TMEV entry and
infection by viruses of both TMEV groups in a receptor-negative BHK-21 cell variant (R26). The sequence of this clone is
96.4% identical to the human UDP-galactose transporter (UGT), which belongs to a family of nucleotide-sugar transporter
proteins involved in the biosynthesis of complex carbohydrate structures in the trans-Golgi network. UGT mRNA from R26
cells was found to have a 490-nucleotide deletion involving the C-terminal amino acids 255 to 392 and 81 nucleotides of the
39 noncoding region. These results suggest two possibilities by which UGT may mediate TMEV entry and infection. The most
likely one relates to the transporter function of adding galactose to another receptor protein. This possibility suggests the
requirement for a specific glycoprotein interaction for GDVII virus cell binding and entry, e.g., galactose for GDVII and sialic
acid for BeAn. Alternatively, UGT might be a TMEV receptor itself, acting via UGT cycling to the cell surface. © 2001 Academic
PressKey Words: Theiler’s murine encephalomyelitis virus; Theiler’s virus; virus receptor; picornavirus; persistent infection;
nucleotide-sugar transporter; glycoprotein.INTRODUCTION
Theiler’s murine encephalomyelitis viruses (TMEV) are
members of the genus Cardiovirus in the family Picorna-
viridae, which includes a separate serogroup formed by
Mengo and encephalomyocarditis viruses. TMEV are
divided into two groups based on neurovirulence in mice
following intracerebral inoculation. High-neurovirulence
TMEV, such as GDVII and FA, cause fatal encephalitis,
while less virulent strains, such as BeAn and DA, are
characterized by at least a 105-fold increase in the mean
50% lethal dose. The low-neurovirulence TMEV cause a
persistent infection in the central nervous system of
susceptible mouse strains that results in immune-medi-
ated as well as viral destruction of oligodendrocytes, and
hence, demyelination (Blakemore et al., 1988; Clatch et
al., 1986; Gerety et al., 1994; Rodriguez et al., 1983). This
animal model is a valuable experimental analogue of
multiple sclerosis.
A major determinant of virus host range and tissue and
cell tropism in animal infections is the binding of a virus
to the surface of susceptible cells. This event is usually
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llipton@merle.acns.nwu.edu.
0042-6822/01 $35.00
Copyright © 2001 by Academic Press
All rights of reproduction in any form reserved.
336a highly specific interaction involving the recognition of a
host cell surface protein(s) by unique structural features
on the virion coat (for nonenveloped viruses). Receptors
have been identified for many viruses, including picor-
naviruses (reviewed in Schneider-Schaulies, 2000).
TMEV use at least two molecules for attachment and
cell entry as suggested by Jnaoui and Michiels (1999).
Cell surface sialic acid is bound by the low neuroviru-
lence TMEV DA and BeAn, but not the highly virulent
TMEV GDVII (Fotiadis et al., 1991; Zhou et al., 1997).
Treatment of cells with neuraminidase to remove sialic
acid (Fotiadis et al., 1991) or addition of the sialic acid
receptor blocking mimic, sialyllactose (Zhou et al., 1997),
to the virus prevents binding of BeAn virus to cells but
has no effect on the GDVII binding. Sialyllactose also
prevents infection with BeAn and DA but not GDVII virus
(Zhou et al., 1997, 2000).
In a high-resolution crystallographic analysis of the
complex sialyllactose-DA virus, N-acetyl neuramic acid
binds to a positively charged pocket on the viral surface,
forming noncovalent hydrogen bonds with the four virus
capsid protein residues VP2 161Q, VP2 174G, VP2 163A,
and VP3 232Q (Zhou et al., 1997). Since nonenveloped
viruses do not fuse with cellular membranes, direct bind-
ing to a protein receptor is presumably required for virus
entry. Therefore, infection by low-neurovirulence TMEV is
most likely initiated by two-step attachment: initial con-
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337UDP-GALACTOSE TRANSPORTER AND THEILER’S VIRUS ENTRYtact with sialic acid through a lower affinity electrostatic
interaction and subsequent transfer to a higher affinity
receptor, leading to pH-dependent receptor-mediated
endocytosis (Heinz Zeichhardt, personal communica-
tion). For high-neurovirulence TMEV, infection is presum-
ably mediated through one-step attachment by direct
binding to the receptor protein.
We show here that the UDP-galactose transporter
(UGT), a member of a family of trans-Golgi network (TGN)
nucleotide-sugar transporter proteins associated with
the biosynthesis of complex carbohydrates, mediates
cell entry and infection by viruses of both TMEV groups
in a receptor-negative BHK-21 cell variant. UGT might be
the TMEV receptor acting via UGT cycling to the cell
surface or might simply add galactose to another recep-
tor protein. The latter possibility suggests the require-
ment for a specific glycoprotein interaction for GDVII
virus cell binding and entry.
RESULTS
Identification of a cDNA clone mediating GDVII virus
entry in R26 cells
Extensive screening of animal and human cell lines
has failed to reveal a TMEV receptor-negative cell line,
perhaps because the TMEV receptor is widely ex-
pressed in eukaryotic cells. R26 cells, a BHK-21 cell
variant selected for TMEV resistance (Hertzler et al.,
2000), was used to screen a BHK-21 cell cDNA library.
R26 cells transiently transfected with pools of a BHK-21
cDNA library were infected with GDVII virus and
screened for viral entry and infection by immunoperoxi-
dase staining using a rabbit polyclonal antibody to TMEV.
cDNA pools that yielded the highest number of infected
cells were subjected to repeated subdivisions until a
single plasmid DNA, 241, mediating viral entry and infec-
tion was isolated. Four additional independent clones,
with the same nucleotide sequence as clone 241, and
mediating viral entry and infection, were also isolated. A
Blast search of the protein databases revealed an almost
identical match with the human UDP-galactose trans-
porter gene, e.g., 96.4% identity (Miura et al., 1996).
Hamster and human UGT mediate binding and
infection of both low- and high-neurovirulence TMEV
R26 cells transiently transfected with hamster UGT
clone 241 were susceptible to infection by both GDVII
and BeAn viruses (Fig. 1A), and to DA virus, another
low-neurovirulence strain, and Vilyuisk virus, a highly
divergent TMEV (not shown). In addition, cytopathic ef-
fect developed at a similar rate over 12 h in 40–60% of
transfected R26 cells (the transfection efficiency) with
GDVII and BeAn viruses as in parental BHK-21 cells,
indicating that UGT conferred susceptibility to the com-
plete infectious cycle. The expression vector containing
5
Uthe human UGT (pMKIT-neo-hUGT-cHA) also mediated
infection of BeAn (Fig. 1A) and GDVII (not shown) in
transfected R26 cells. In addition, no virus replication
was seen following infection of R26 cells with GDVII and
BeAn viruses, whereas expected levels of virus replica-
tion were observed in these cells transfected with the
hamster and human UGTs as determined from the yield
of PFU/cell (Table 1).
Cell membranes of hamster or human UGT-trans-
fected R26 cells solubilized in 1% octylglucoside-medi-
ated binding of 32P-labeled BeAn virus in a virus overlay
inding assay (VOPBA), whereas mock-transfected R26
ells showed no viral binding (Fig. 1B). GDVII and BeAn
irus binding to transfected R26 cells but not control
ransfected R26 cells was also observed with flow cy-
ometry (not shown). To further confirm the role of UGT in
MEV entry, UGT-defective Lec 8 cells were resistant to
eAn virus (Fig. 2) and to GDVII virus (not shown),
hereas expression of hamster UGT clone 241 in these
ells rendered them susceptible to both viruses (Fig. 2,
hown for BeAn only).
ltered N-linked glycans on R26 cells
To analyze the structures of the carbohydrate chains
n the cell surface, BHK-21 and R26 cells were incubated
ith FITC-conjugated GSII, which recognizes a- or
b-linked GlcNAc residues, and with biotinylated wheat
germ agglutinin (WGA), which recognizes sialic acid res-
idues on terminal oligosaccharides, and analyzed by
flow cytometry. As compared with BHK-21 cells (Figs. 3A
and 3D), R26 cells bound increased amounts of Griffonia
simplicifolia lectin (GSII) and lower amounts of WGA
(Figs. 3B and 3E, respectively), consistent with a defect in
UGT transport activity. R26 cells transiently transfected
with hamster UGT showed reduced GSII-binding in 40–
60% of cells, consistent with the addition of galactose to
GlcNAc, and a minimal increase in WGA-binding by
mean fluorescence intensity. A similar change in WGA
binding was seen when R26 cells were transiently trans-
fected with human UGT (not shown). It is not clear why
expression of UGT did not lead to a pattern of WGA-
binding more similar to that of BHK-21 cells; however,
sufficient cell sialylation occurred for BeAn and DA virus
binding and entry into transfected R26 cells.
Comparison of the hamster and human UGTs
Clone 241 contained a total of 2298 nucleotides of the
hamster UGT cDNA (Fig. 4A). The 1177 nucleotide open
reading frame was 98.1% identical to the human homo-
logue; however, the 1113 nucleotides of the 39 noncoding
region was divergent with only 63.5% identity. The N-
terminal sequences of the coding region and 59 noncod-
ng region were G9C-rich, and only 11 nucleotides of the
9 noncoding region were obtained by 59 RACE. Hamster
GT consisted of 392 amino acids, one residue less than
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338 HERTZLER, KALLIO, AND LIPTONthe human homologue due to a deletion in the C-termi-
nus, and was 96.4% identical to human UGT at the amino
acid level (Fig. 4B). The UGT protein structure with 10
transmembrane spanning regions (shaded areas Fig. 4B)
FIG. 1. (A) Immunohistochemical stain for viral antigen in R26 cells a
transfected with a UGT expression vector, either pCMV-SPORT-hams
monolayers in 35-mm wells were transfected with 1–2 mg of DNA in 6
MEM medium with 10% FBS and infected with virus 48 h later. T
Magnification, 3400. (B) Autoradiogram of virus overlay protein blot
embranes, the lack of binding to membranes of mock-transfected R26
ither the hamster or the human UGT plasmid.
TABLE 1
Viral Titers in Transfected R26 Cells Following Infection with TMEV
Transfected plasmida
PFU/cell 6 SEb
GDVII BeAn
pCMV-SPORT-bgal 0.29 6 0.1 0.13 6 0.02
CMV SPORT hamster UGT 320 6 36.0 18.2 6 6.3
MKIT-human UGT-cHA 370 6 78.1 16.2 6 4.2
a BHK-21 R26 monolayers were infected with GDVII and BeAn viruses
t an m.o.i. of 30, 48 h following transfection using Lipofectamine and
he expression plasmids shown above (see Materials and Methods). In
his experiment the transfection efficiency as determined by staining for
bgal was approximately 30%.
b Viral assays were done on both the supernatant and the cells of
infected cell monolayers, and the titers are expressed in PFU/cell.is based on the membrane topology model proposed by
Eckhardt et al. (1999) for nucleotide-sugar transporters.
Only one of the 13 amino acid differences between the
hamster and human proteins was present in a trans-
membrane domain. Four hydrophilic loops that face the
Golgi lumen and potentially form extracellular loops on
the cell surface are also predicted (Fig. 4B).
UGT mutation in R26 and related cell lines
Northern blot analysis of mRNA from R26 and BHK-21
cells using a 32P-labeled probe for hamster UGT revealed
a 0.5-kb deletion in UGT mRNA of R26 cells compared to
the expected 2.4-kb size of UGT mRNA in BHK-21 cells.
Analysis of five other TMEV receptor-negative clones
isolated from BHK-21 cells at the same time as R26 cells
also revealed this deletion (results not shown). Cycle
sequencing of RT-PCR-amplified cDNA from total RNA
extracted from four of the cell lines (R26, R19, R33, and
R44) indicated an identical 490 nucleotide deletion in
i with BeAn or GDVII viruses. Cells were not infected (top) unless first
(clone 241) or human pMKIT-neo-hUGT-cHA (bottom). Subconfluent
pofectamine (Gibco BRL). After 5 h, cells were washed and refed with
tion efficiency was 40–70% as monitored with pCMV-SPORT-bGal.
(VOPBA) showing binding of 32P-labeled BeAn virus to BHK-21 cell
and the restoration of membrane binding of R26 cells transfected witht 8 h p
terUGT
ml of Li
ransfec
assayUGT; the other two cell lines were not sequenced. The
deletion extended from nucleotide 781 to 1271 (Fig. 5B),
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339UDP-GALACTOSE TRANSPORTER AND THEILER’S VIRUS ENTRYresulting in deletion of the UGT C-terminal amino acids
255 to 392 and of 81 nucleotides of the 39 noncoding
region. This deletion also resulted in a frameshift and
FIG. 2. Immunohistochemical stain for TMEV viral antigen in Lec8
cells at 8 h after infection with BeAn virus. UGT-defective Lec8 cells
were not susceptible to infection (A), whereas 48 h following transfec-
tion with pCMV-SPORT-hamsterUGT (clone 241), infection was ob-
served (B). Magnification, 3400.
FIG. 3. FACS analysis of lectin binding. BHK-21 cells (A,D), R26 cell
ncubated with GS-II-FITC (A–C) and biotinylated WGA and avidin-FITC (D–F
aterials and Methods. The lighter staining lines are the controls and represeaddition of 20 more amino acids to the already truncated
UGT. Thus, the fourth extracellular domain and trans-
membrane domains 8–10 of UGT were deleted in the
mutant cell lines with the mutant protein now having 276
amino acids.
Comparison of murine UGT amino acid sequences in
C57/BL6 and 129/Sv mice resistant to TMEV-induced
demyelinating disease
Recently, the use of polymorphic markers to screen
(129/Sv Ifngr2/2 3 C57BL/6) F2 Ifngr2/2 mice with
linical demyelinating disease revealed significant link-
ge with clinical disease for marker D11Mit179 on chro-
osome 11, with susceptibility conferred by the C57BL/6
llele at this locus (Aubagnac et al., 1999). Since UGT is
ocated at 55.5 cM, close to D11Mit179 at 52.0 cM (Blake
t al., 2000), and a mutation in UGT could affect virus
nfection and clinical disease, we sequenced the UGT
pen reading frames of both parental mouse strains
129Sv and C57BL/6) and the susceptible SJL mouse
train for mutations or deletions and compared these
equences to those of the human, hamster, and resistant
ALB/c mouse. Except for mutations S260T and Q261R
n loop 4 of the 129Sv mouse (also present in the BALB/c
ouse; Fig. 4B), which theoretically could affect (reduce)
irus binding and 129Sv susceptibility if UGT is a TMEV
eceptor, the sequences were relatively conserved for
he two parental mouse strains.
, and R26 cells transfected with the hamster UGT plasmid (C,F) weres (B,E)
) (darker lines) and analyzed by flow cytometry as described under
nt incubation of cells without reagent (A–C) or with avidin-FITC (D–F).
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341UDP-GALACTOSE TRANSPORTER AND THEILER’S VIRUS ENTRYDISCUSSION
In this study, we have identified a clone from a BHK-21
ell cDNA library that mediates TMEV entry and infec-
ion. The sequence of this clone was nearly identical to
he human UGT (Miura et al., 1996), which belongs to a
amily of nucleotide-sugar transporter proteins involved
n the biosynthesis of complex carbohydrate structures
Kawakita et al., 1998). These transporters are located in
he TGN and carry nucleotide sugars produced outside
he Golgi apparatus to the organelle, where they serve
s substrates for the elongation of carbohydrate chains
n membrane proteins by glycotransferases. In the case
f UGT, loss of galactose results in the loss of a2,3-sialic
acid residues on terminal oligosaccharides. Several res-
ident TGN proteins have been shown to cycle to the
plasma membrane in exocytic transport vesicles (along
with their glycoprotein products) and return to the TGN
via the endocytic pathway (Ladinsky and Howell, 1993;
Shukla et al., 1999). Thus, the nucleotide-sugar transport-
ers might be expressed on the cell surface.
Our results suggest two possibilities by which UGT
may mediate TMEV entry and infection. The most likely
one relates to the transporter function of UGT. The facts
FIG. 4. (A) Nucleotide sequence of the hamster UGT showing the c
he 59 noncoding region. The start and stop codons for translation are
mino acid sequence with that of the human and four inbred mouse s
opology model for nucleotide sugar transporters (Eckhardt et al., 199
FIG. 5. (A) Northern blot analysis showing the expected 2.4-kb size o
GT from R26 cells (lane 2). Messenger RNA (5 mg) isolated from each c
plus nylon membrane, hybridized with 5 3 106 cpm of a random-primed
to a phosphorimager screen as described under Materials and Met
nucleotides at the site of the deletion of 490 nucleotides.ydrophilic loops that face the Golgi lumen and, putatively, the extracellular sp
he C57BL/6 and 129Sv strains are designated by a (1) below the sequencethat R26 cells were selected based on resistance to
BeAn virus infection and that UGT mRNA from R26 cells
has a 0.5-kb deletion of the carboxy-terminal part of the
coding region suggest that the deletion is responsible for
the loss of UGT activity, and in turn, for TMEV resistance.
Recently, Eckhardt et al. (1998) reported mutations in the
CMP-sialic acid transporter coding region of five inde-
pendent clones of CHO mutants belonging to the Lec2
complementation group that are unable to translocate
CMP-sialic acid into the Golgi lumen. Three of the clones
had deletions and one had an insertion that prevented
subcellular targeting of the CMP-sialic acid transporter
to the Golgi, while one clone with a point mutation
appeared to affect transport activity directly (Eckhardt et
al., 1998). Based on these results and on the highly
conserved sequences and hydrophobicity plots of the
nucleotide-sugar transporters in yeast, leishmania, nem-
atodes, and mammals (Eckhardt et al., 1999), deletion of
139 C-terminal amino acids spanning the last three
transmembrane domains in hamster UGT probably af-
fects subcellular targeting rather than transport activity;
however, this remains to be established.
Since the low-neurovirulence TMEV attach to cells by
open reading frame, the 39 noncoding region, and 11 nucleotides of
lized, boldfaced, and underlined. (B) Comparison of the hamster UGT
C57BL/6 (B6), 129Sv (129S), SJL, and BALB/c. A proposed membrane
dicts 10 transmembrane domains (shaded and labeled TM) and four
mRNA from parental BHK-21 cells (lane 1) and a 0.5-kb deletion in the
was electrophoresed in a 1.0% agarose gel, transferred to a Bright-star
DNA probe from hamster UGT labeled with a-[32P]dCTP, and exposed
B) Sequence of the UGT RNA from R26 cells, showing the flankingomplete
capita
trains:
9) pref UGT
ell line
700-bpace at the cell surface. Three potentially significant changes between
s.
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342 HERTZLER, KALLIO, AND LIPTONinitial contact with sialic acid through a lower affinity
electrostatic interaction, failure to add galactose to N- or
O-linked oligosaccharides prevents addition of terminal
a2,3-sialic acid residues and thereby attachment of
BeAn and DA viruses to sialic acid. Since the low-neu-
rovirulence TMEV do not attach to R26 cells, these TMEV
strains must bind to terminal a2,3 and not to branched
hain a2,6-sialic acid linkages on proximal GlycNAc res-
dues. Had-1 cells are resistant to Newcastle disease
irus (NDV), which also uses sialic acid as a receptor
Hara et al., 2000), and the genetic defect in these cells
s also complemented by UGT cDNA (Yoshioka et al.,
997). In contrast, the R26 UGT deletion abrogated bind-
ng and infection by the high-neurovirulence TMEV strain
DVII, which does not bind sialic acid, suggesting that
DVII recognizes galactose as an important component
f the primary receptor. Recently, the galactose-specific
ectin Ricinus agglutinin was shown to inhibit infection by
human and animal strains of rotavirus, indicating that
rotaviruses also have a specific carbohydrate require-
ment other than sialic acid, e.g., galactose, in binding a
glycoprotein or glycolipid receptor (Jolly et al., 2000).
While less likely, it remains possible that UGT is a
TMEV receptor based on several lines of indirect evi-
dence as follows: (1) UGT may cycle to the cell surface
like several other TGN proteins; (2) TMEV binds to a
34-kDa membrane protein in a VOPBA (Kilpatrick and
Lipton, 1991), and UGT migrates as a 34- to 36-kd protein
in SDS–PAGE (Yoshioka et al., 1997) (data not shown);
and (3) loop 4, which would face the extracellular space,
theoretically large enough (17 amino acids) to bind in the
receptor attachment site on the virion by analogy with
rhino- and enterovirus cell receptor recognition (Ross-
mann et al., 2000), was deleted in R26 cells. Availability
of antibodies to UGT and loops 3 and 4 will help deter-
mine whether TMEV binding and infection of mammalian
cells can be inhibited. UGT loops 1 and 2 are not ex-
pected to be relevant in virus binding. Since the authen-
tic AUG codon was absent in hamster clone 241 (see
Materials and Methods), an AUG located in transmem-
brane domain 2 was used, resulting in a functional pro-
tein without loop 1 that still mediated TMEV binding.
Loop 2 is only seven residues in size and would be too
small to bind in the receptor attachment site on the
virion. This result also suggests that transmembrane
domains 1 and 2 can be deleted without affecting sub-
cellular targeting, dimerization, and galactose transport
in the artificial context of overexpression of UGT. Two
exceptions to the 10-transmembrane model of the nucle-
otide-sugar transporters exist; one lacks the first trans-
membrane domain and the other lacks the first two
transmembrane domains (reviewed in Eckhardt et al.,
1999).
The proximity of the UGT locus to the clinical disease
marker D11Mit179 on chromosome 11 is intriguing
(Aubagnac et al., 1999). In this regard, it is important to
u
onote that the low-neurovirulence strains not only attach
to sialic acid but that sialic acid attachment appears to
be required for TMEV persistence and demyelinating
disease (Zhou et al., 1997, 2000; also unpublished data),
parameters for establishing linkage in this genetic study
(Aubagnac et al., 1999). However, since the parental
C57BL/6 and 129Sv strains are not known to have ab-
normalities of cell surface sialylation, one would not
expect to find UGT mutations affecting transporter func-
tion in these mice. However, from the sequence compar-
isons shown in Fig. 4B, the only mutation likely to affect
UGT function is S304C in transmembrane domain 9 of
the C57BL/6 mouse. Since S304 is conserved in other
species and in the other mouse strains, this mutation
would be predicted to reduce UGT activity, and in turn,
confer resistance rather than susceptibility to TMEV in-
fection. If UGT is a TMEV receptor, mutations S260R and
Q261R in loop 4 in the 129Sv mouse may influence TMEV
infection. Further experiments will be necessary to de-
termine if D11Mit179 and UGT are the same and to
determine the role of these murine UGT mutations in
TMEV entry and infection.
MATERIALS AND METHODS
Cells
Hamster BHK-21 cells were maintained in Dulbecco’s
modified Eagle medium (DMEM) supplemented with 2
mM L-glutamine, 100 mg/ml streptomycin, 100 U/ml pen-
cillin, 7.5% fetal bovine serum (FBS), and 6.5 mg/ml
ryptose phosphate broth (Gibco BRL) at 37°C in 5%
O2-95% air. Receptor-negative BHK-21 cells, designated
26, were selected by resistance to BeAn virus infection
nd maintained as for parental BHK-21 cells (Hertzler et
l., 2000). Hamster Lec8 cells, which are defective in
GT activity and have truncated cell surface glycans with
lcNAc residues at their termini (Deutscher and Hirsch-
erg, 1986; Eckhardt et al., 1996), were grown and main-
ained in minimum essential medium-a (Gibco BRL) sup-
lemented with 2 mM L-glutamine, 100 mg/ml streptomy-
in, 100 U/ml penicillin, 10% FBS. Virus infections were
arried out on 90% confluent monolayers in medium
ontaining 1% FBS.
iruses
The origin and passage history of BeAn (Pevear et al.,
987), GDVII (Pevear et al., 1988), DA (Lipton, 1975), and
ilyiusk (Pritchard et al., 1992) TMEV viruses has been
escribed. Virus stock were prepared as clarified lysates
n BHK-21 cells, with titers .108 PFU/ml.
DNA library construction and screening
Total cellular RNA was isolated from BHK-21 cells
sing TRIzol (Gibco BRL), and mRNA was selected by
ligo(dT) cellulose chromatography. Five micrograms of
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343UDP-GALACTOSE TRANSPORTER AND THEILER’S VIRUS ENTRYmRNA was transcribed into double-stranded (ds) cDNA
using an oligo(dT)–NotI primer adaptor and Superscript II
reverse transcriptase (Gibco BRL) for first-strand synthe-
sis. dsDNA was blunt-ended with T4 DNA polymerase
and ligated with a SalI adaptor for unidirectional cloning
into the SalI/NotI restriction endonuclease sites in
pCMV-SPORT1 (Gibco BRL). Plasmids with cDNA inserts
were electroporated into Escherichia coli DH10B cells
sing a BTX Electro Cell Manipulator 600, resulting in a
ibrary of 6 3 106 clones. The library was amplified on
100-mm2 LB agar plates containing 100 mg/ml ampicillin,
and colonies were harvested into LB broth by scraping
and frozen in 200 aliquots with 2.9 3 104 colonies per
liquot. For the first round of transfection, plasmid DNA
as purified with Quantum Prep (Bio–Rad) from 20 pools,
ach containing 10 aliquots from the amplified cDNA
ibrary.
ransfection and assay for TMEV entry
R26 cells in 35-mm2 six-well plates were transfected
y means of Lipofectamine (Gibco BRL) (1–2 mg of DNA
n 6 ml of Lipofectamine). After 48 h, monolayers were
infected with GDVII virus (30 PFU/cell) and 8 h later
assayed for viral antigen using a rabbit anti-TMEV anti-
body and secondary goat anti-rabbit IgG conjugated to
immunoperoxidase. In each experiment, uninfected
transfected monolayers and GDVII-infected BHK-21 cells
were included for staining.
Reagents
The plasmid pCMV-SPORT-bGal was purchased com-
mercially (Gibco BRL) and human pMKIT-hUGT-cHA was
provided by M Kawakita, Tokyo, Japan.
Dideoxynucleotide sequencing
Selected plasmid clones of hamster UGT cDNAs and
total RNA extracted from the livers of the C57BL/6, 129Sv,
and SJL mice and amplified by RT-PCR were sequenced
with the ABI Prism dRhodamine terminator cycle se-
quencing ready reaction kit using the ABI Prism 310
genetic analyzer (PE Applied Biosystems).
N-terminal sequencing of hamster UGT
The nucleotide sequence of the hamster UGT six N-
terminal amino acids was not found within clones of the
cDNA library. Thus, a modification of the 59 rapid ampli-
fication of cDNA ends (59 RACE) method (Gibco BRL)
was used to generate the missing sequence. First-strand
synthesis was performed using 5 mg of BHK-21 cell total
NA, 10 pmol of the gene-specific primer (CACCAGCCT-
CTGTGCCTGGACAAT), and 15 U of ThermoScript re-
erse transcriptase for 60 min at 55°C. dC tailing proce-
ure was carried out with a 23 concentration of PCRx
nhancer (Gibco BRL). Products of a nested set PCR-
s
wmplification were cloned into the pGEM-T vector (Pro-
ega), transformed into E. coli JM109 cells, and clones
ere selected and sequenced as described above.
orthern hybridization
Total cellular RNA was isolated from cells using TRIzol
Gibco BRL) and mRNA was selected by oligo(dT) cellu-
ose chromatography. mRNA was resuspended in RNA
oading buffer (50% formamide, 7% formaldehyde, 0.04%
romophenol blue in 200 mM 3-[N-morpholino]propane-
ulfonic acid, pH 7.0, 50 mM sodium acetate, 10 mM
DTA) and electrophoresed in a 1% agarose gel at 80–90
for 1.5 h. The gel was soaked in 53 SSC (203 SSC 5
M NaCl, 0.3 M sodium citrate) with 10 mM NaOH for 30
in. RNA was passively transferred to a Bright-star plus
ylon membrane (Ambion), treated with short-wave-
ength UV light for 2 min, and prehybridized with Ultra-
yb solution (Ambion) for 1 h at 42°C. At least 5 3 106
cpm (specific activity 1 3 109 cpm/mg) of a random-
rimed 700-bp DNA probe spanning nucleotides 1341–
014 of hamster UGT labeled with a-[32P]dCTP (Amer-
sham) was added to the prehybridization solution, and
hybridization was carried out overnight at 42°C. Mem-
branes were washed once with 13 SSC and 0.1% SDS
for 20 min at 24°C, and three times with 0.23 SSC and
0.1% SDS for 20 min each at 68°C, dried, and exposed to
a Molecular Dynamics phosphorimager screen to detect
the 32P-labeled hybridized probe.
irus overlay protein binding assay (VOPBA)
Cell extracts transferred to nitrocellulose filters were
creened for viral binding with a 96-well dot-blot appa-
atus (Schleicher and Schuell) as described (Kilpatrick
nd Lipton, 1991). Briefly, filters were incubated in block-
ng buffer (50 mM Tris–HCl, pH 7.4, 150 mM NaCl, 5 mM
DTA, 0.25% gelatin, 0.05% Tween-20 containing 5% bo-
ine serum albumin) for 1 h at 24°C to prevent nonspe-
ific binding. After removing the buffer, 106 cpm of 32P-
labeled, purified virus was added to fresh buffer and
incubated with the filter for 1 h at 24°C with gentle
agitation. Filters were washed three times in buffer con-
taining 25 mM Tris–HCl, pH 7.4, 150 mM NaCl, and 0.3%
Tween-20, air-dried, and exposed to Kodak X-OMAT-AR
film.
Flow cytometry
For flow cytometry, 106 cells were washed once in cold
phosphate-buffered saline (PBS), pH 7.2, containing 2.0%
bovine serum albumin and 0.02% sodium azide (PBS–
FACS) and blocked by preincubation with 10 ml of normal
goat serum and 10 ml of normal human serum. Cells
were incubated with 200 ng of biotinylated wheat germ
agglutinin (Triticum vulgaris; Sigma) or 1 mg of Griffoniaimplicifolia lectin II (Vector Burlingame, CA) conjugated
ith fluorescein isothiocyanate (FITC) for 30 min on ice,
w
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344 HERTZLER, KALLIO, AND LIPTONwashed two times with PBS–FACS, and for WGA, incu-
bated with 1 mg avidin-FITC for 30 min on ice. After two
ashes, the cells were fixed with 1% paraformaldehyde
nd analyzed on a FACSCalibur (Becton–Dickinson, Palo
lto, CA).
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